Larimar Therapeutics Inc. (LRMR)

AI Score

Unlock

1.98

-0.22 (-10.00%)

At close: Apr 03, 2025, 3:59 PM

1.91

-3.29%

Pre-market: Apr 04, 2025, 08:10 AM EDT

Larimar Therapeutics Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	33.22M	26.75M	26.82M	70.1M	68.15M	1.01M	49.33M	40.78M	32.35M	35.59M	58.1M	35.52M	9.94M
Short-Term Investments	150.24M	60.04M	91.6M	n/a	24.49M	43.05M	68.73M	61.27M	96.84M	149.48M	57.36M	n/a	n/a
Long-Term Investments	n/a	1.34M	1.34M	1.34M	1.34M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	630K
Other Long-Term Assets	1.2M	659K	638K	669K	419K	90K	57K	57K	61K	94K	242K	743K	n/a
Receivables	n/a	n/a	n/a	208K	32K	n/a	1.54M	946K	347K	1.32M	n/a	1.62M	n/a
Inventory	n/a	n/a	n/a	-208K	-32K	3.16M	n/a	n/a	1.00	n/a	n/a	n/a	n/a
Other Current Assets	11.85M	709K	n/a	279K	251K	577K	1.73M	1.93M	1.36M	1.71M	1.74M	224K	389K
Total Current Assets	195.3M	90.17M	120.74M	72.2M	97.95M	4.75M	121.33M	104.92M	130.9M	188.11M	117.2M	37.36M	10.32M
Property-Plant & Equipment	3.72M	3.76M	3.69M	4.46M	4.98M	361K	375K	528K	661K	902K	79K	37K	32K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.92M	5.76M	5.67M	6.46M	6.73M	451K	432K	585K	722K	996K	321K	780K	662K
Total Assets	200.22M	95.94M	126.41M	78.67M	104.69M	5.2M	121.76M	105.51M	131.62M	189.11M	117.52M	38.14M	10.99M
Account Payables	2.42M	1.28M	1.69M	1.66M	2.63M	3.54M	909K	3.02M	2.57M	7.5M	2.35M	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	-5.46M	n/a	-2.57M	-2.94M	n/a	n/a	n/a
Short-Term Debt	1.06M	n/a	611K	594K	515K	n/a	5.46M	n/a	3.59M	2.94M	1.38M	n/a	n/a
Other Current Liabilities	20.87M	n/a	5.75M	4.9M	3.98M	1.63M	4.65M	4.27M	6.3M	9.05M	3.17M	2.87M	2.86M
Total Current Liabilities	24.36M	9.51M	10.71M	8.85M	8.99M	5.89M	13.31M	7.29M	9.89M	16.54M	6.9M	2.92M	2.93M
Long-Term Debt	4.06M	n/a	n/a	n/a	n/a	n/a	15.19M	20M	n/a	3.45M	6.18M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1	n/a	n/a	n/a
Total Long-Term Liabilities	4.06M	4.71M	4.8M	5.41M	6M	14.92M	15.19M	20M	n/a	3.45M	6.18M	n/a	n/a
Total Liabilities	28.41M	14.21M	15.5M	14.25M	14.99M	5.89M	28.49M	27.29M	9.89M	20M	13.08M	2.92M	2.93M
Total Debt	5.12M	5.55M	5.41M	6M	6.52M	97K	20.64M	20M	3.59M	6.39M	7.56M	n/a	n/a
Common Stock	64K	43K	43K	18K	15K	6K	37K	27K	27K	27K	23K	1K	1K
Retained Earnings	-269.16M	-188.55M	-151.6M	-116.25M	-65.61M	-23.13M	-350.94M	-289.58M	-237.55M	-179.67M	-105.39M	-68.91M	-54.88M
Comprehensive Income	n/a	81K	-31K	-0.00	1K	35K	-33K	-58K	-80K	-207K	-35K	n/a	n/a
Shareholders Equity	171.81M	81.72M	110.9M	64.41M	89.69M	-694K	93.27M	78.22M	121.73M	169.11M	104.44M	35.22M	8.06M
Total Investments	150.24M	61.38M	91.6M	1.34M	24.49M	43.05M	68.73M	61.27M	96.84M	149.48M	57.36M	n/a	630K